+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID07034664

Using Intestinal Ultrasound to Predict How Well Guselkumab Works in Adults With Moderate to Severe Crohns Disease

Led by The Third Xiangya Hospital of Central South University · Updated on 2025-06-24

50

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Crohns disease CD is a chronic inflammatory condition affecting the intestines and other organs, leading to serious complications like obstruction and fistulas. This research focuses on moderate-to-severe CD and evaluates the use of guselkumab, a targeted drug that blocks specific inflammation pathways. The study explores how intestinal ultrasound, a safe and convenient imaging method, might help predict how well patients respond to guselkumab treatment, aiming to improve personalized care. Guselkumab works by blocking the interleukin-23 IL-23 p19 subunit to reduce inflammation in the intestines. Patients with moderate-to-severe CD who are starting guselkumab therapy within one month of baseline assessments will be observed. The study uses intestinal ultrasound and endoscopy at the start and follows patients over about 56 weeks to monitor bowel wall thickness and treatment response. This approach may help doctors adjust treatment plans based on how patients respond. Participants will undergo intestinal ultrasound and endoscopy to assess disease status before starting guselkumab. Researchers will regularly monitor bowel wall thickness for around 56 weeks to evaluate treatment effects. The study will collect data on symptoms, side effects, and disease activity to better understand how intestinal ultrasound can guide therapy. This observational study aims to provide evidence supporting individualized treatment plans for people with moderate-to-severe Crohns disease.

CONDITIONS

Brief Title

IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study

Research Team

L

Li Tian

Y

Yuwei Wu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here